Full Text View
Tabular View
No Study Results Posted
Related Studies
D4T or Abacavir Plus Vitamin Enhancement in HIV-Infected Patients (DAVE)
This study has been completed.
Study NCT00143702   Information provided by University of British Columbia
First Received: August 31, 2005   Last Updated: September 24, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Acidosis, Lactic
Additional conditions recognized in this trial
Acidosis
More general conditions related to this trial
Acid-Base Imbalance
Metabolic Diseases
Interventions listed in this trial
d4T
Abacavir
Additional drug interventions recognized in this trial
Riboflavin
Thiamine
More general drug interventions related to this trial
Anti-HIV Agents
Anti-Infective Agents
Anti-Retroviral Agents
Antiviral Agents
Dermatologic Agents
Enzyme Inhibitors
Growth Substances
Micronutrients
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Photosensitizing Agents
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Reverse Transcriptase Inhibitors
Therapeutic Uses
Vitamin B Complex
Vitamins
Sponsors listed in this trial
University of British Columbia
GlaxoSmithKline
Canadian HIV Trials Network


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services